BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 21515913)

  • 1. Mesothelin overexpression promotes autocrine IL-6/sIL-6R trans-signaling to stimulate pancreatic cancer cell proliferation.
    Bharadwaj U; Marin-Muller C; Li M; Chen C; Yao Q
    Carcinogenesis; 2011 Jul; 32(7):1013-24. PubMed ID: 21515913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mesothelin confers pancreatic cancer cell resistance to TNF-α-induced apoptosis through Akt/PI3K/NF-κB activation and IL-6/Mcl-1 overexpression.
    Bharadwaj U; Marin-Muller C; Li M; Chen C; Yao Q
    Mol Cancer; 2011 Aug; 10():106. PubMed ID: 21880146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mesothelin-induced pancreatic cancer cell proliferation involves alteration of cyclin E via activation of signal transducer and activator of transcription protein 3.
    Bharadwaj U; Li M; Chen C; Yao Q
    Mol Cancer Res; 2008 Nov; 6(11):1755-65. PubMed ID: 19010822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A tumorigenic factor interactome connected through tumor suppressor microRNA-198 in human pancreatic cancer.
    Marin-Muller C; Li D; Bharadwaj U; Li M; Chen C; Hodges SE; Fisher WE; Mo Q; Hung MC; Yao Q
    Clin Cancer Res; 2013 Nov; 19(21):5901-13. PubMed ID: 23989979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-6 trans-signalling directly induces RANKL on fibroblast-like synovial cells and is involved in RANKL induction by TNF-alpha and IL-17.
    Hashizume M; Hayakawa N; Mihara M
    Rheumatology (Oxford); 2008 Nov; 47(11):1635-40. PubMed ID: 18786965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Melittin enhances apoptosis through suppression of IL-6/sIL-6R complex-induced NF-κB and STAT3 activation and Bcl-2 expression for human fibroblast-like synoviocytes in rheumatoid arthritis.
    Kim SK; Park KY; Yoon WC; Park SH; Park KK; Yoo DH; Choe JY
    Joint Bone Spine; 2011 Oct; 78(5):471-7. PubMed ID: 21354845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human umbilical cord blood-derived stromal cells: a new resource for the proliferation and apoptosis of myeloma cells.
    Gao L; Zhang C; Zhang X; Gao L; Hao L; Chen XH
    Hematology; 2014 Apr; 19(3):148-57. PubMed ID: 23896383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The interleukin-6 receptor Asp358Ala single nucleotide polymorphism rs2228145 confers increased proteolytic conversion rates by ADAM proteases.
    Garbers C; Monhasery N; Aparicio-Siegmund S; Lokau J; Baran P; Nowell MA; Jones SA; Rose-John S; Scheller J
    Biochim Biophys Acta; 2014 Sep; 1842(9):1485-94. PubMed ID: 24878322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The balance of interleukin (IL)-6, IL-6·soluble IL-6 receptor (sIL-6R), and IL-6·sIL-6R·sgp130 complexes allows simultaneous classic and trans-signaling.
    Baran P; Hansen S; Waetzig GH; Akbarzadeh M; Lamertz L; Huber HJ; Ahmadian MR; Moll JM; Scheller J
    J Biol Chem; 2018 May; 293(18):6762-6775. PubMed ID: 29559558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-6 receptor shedding is enhanced by interleukin-1beta and tumor necrosis factor alpha and is partially mediated by tumor necrosis factor alpha-converting enzyme in osteoblast-like cells.
    Franchimont N; Lambert C; Huynen P; Ribbens C; Relic B; Chariot A; Bours V; Piette J; Merville MP; Malaise M
    Arthritis Rheum; 2005 Jan; 52(1):84-93. PubMed ID: 15641051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of soluble interleukin-6 (IL-6) receptor release from corneal epithelial cells and its role in the ocular surface.
    Sugaya S; Sakimoto T; Shoji J; Sawa M
    Jpn J Ophthalmol; 2011 May; 55(3):277-282. PubMed ID: 21523377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-6 induces both cell growth and VEGF production in malignant mesotheliomas.
    Adachi Y; Aoki C; Yoshio-Hoshino N; Takayama K; Curiel DT; Nishimoto N
    Int J Cancer; 2006 Sep; 119(6):1303-11. PubMed ID: 16642474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mesothelin binding to CA125/MUC16 promotes pancreatic cancer cell motility and invasion via MMP-7 activation.
    Chen SH; Hung WC; Wang P; Paul C; Konstantopoulos K
    Sci Rep; 2013; 3():1870. PubMed ID: 23694968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-6/sIL-6R enhances cathepsin B and L production via caveolin-1-mediated JNK-AP-1 pathway in human gingival fibroblasts.
    Yamaguchi T; Naruishi K; Arai H; Nishimura F; Takashiba S
    J Cell Physiol; 2008 Nov; 217(2):423-32. PubMed ID: 18543249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tocilizumab inhibits signal transduction mediated by both mIL-6R and sIL-6R, but not by the receptors of other members of IL-6 cytokine family.
    Mihara M; Kasutani K; Okazaki M; Nakamura A; Kawai S; Sugimoto M; Matsumoto Y; Ohsugi Y
    Int Immunopharmacol; 2005 Nov; 5(12):1731-40. PubMed ID: 16102523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination of interleukin-6 and soluble interleukin-6 receptors induces differentiation and activation of JAK-STAT and MAP kinase pathways in MG-63 human osteoblastic cells.
    Nishimura R; Moriyama K; Yasukawa K; Mundy GR; Yoneda T
    J Bone Miner Res; 1998 May; 13(5):777-85. PubMed ID: 9610741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-6/sIL-6R trans-signalling, but not TNF-alpha induced angiogenesis in a HUVEC and synovial cell co-culture system.
    Hashizume M; Hayakawa N; Suzuki M; Mihara M
    Rheumatol Int; 2009 Oct; 29(12):1449-54. PubMed ID: 19277666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of Toll-like Receptor 2 (TLR2) induces Interleukin-6 trans-signaling.
    Flynn CM; Garbers Y; Lokau J; Wesch D; Schulte DM; Laudes M; Lieb W; Aparicio-Siegmund S; Garbers C
    Sci Rep; 2019 May; 9(1):7306. PubMed ID: 31086276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cathepsin S provokes interleukin-6 (IL-6) trans-signaling through cleavage of the IL-6 receptor in vitro.
    Flynn CM; Garbers Y; Düsterhöft S; Wichert R; Lokau J; Lehmann CHK; Dudziak D; Schröder B; Becker-Pauly C; Rose-John S; Aparicio-Siegmund S; Garbers C
    Sci Rep; 2020 Dec; 10(1):21612. PubMed ID: 33303781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential regulation of neutrophil-activating chemokines by IL-6 and its soluble receptor isoforms.
    McLoughlin RM; Hurst SM; Nowell MA; Harris DA; Horiuchi S; Morgan LW; Wilkinson TS; Yamamoto N; Topley N; Jones SA
    J Immunol; 2004 May; 172(9):5676-83. PubMed ID: 15100312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.